Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects

Saved in:

Bibliographic Details
Main Authors:	D. Olive, B. Savoldo, F. Pastorino, R. Castriconi
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2016/7853028
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
by: Claudia Cantoni, et al.
Published: (2016-01-01)

Metabolic aspects of adoptive immunotherapy of tumors
by: D. B. Kazanskiy, et al.
Published: (2017-10-01)

Exosomes and immune modulation: implications for neuroblastoma immunotherapy
by: Martina Morini, et al.
Published: (2025-05-01)

CRISPR-Cas9 in basic and translational aspects of cancer therapy
by: Maryam Samareh Salavatipour, et al.
Published: (2024-11-01)

Immunotherapy resistance in solid tumors: mechanisms and potential solutions
by: Daniel S. Lefler, et al.
Published: (2024-12-01)

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
by: Mustafa Khasraw, et al.
Published: (2021-07-01)

GP73: the key to unlocking immunotherapies efficacy in solid tumors?
by: Alan L Parker, et al.
Published: (2025-05-01)

Tumor organoids in immunotherapy: from disease modeling to translational research
by: Jing Ma, et al.
Published: (2025-07-01)

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
by: Lawrence Fong, et al.
Published: (2020-05-01)

Case of Treatment of Solid Pseudopapillary Pancreatic Tumor
by: F. S. Rakhimova, et al.
Published: (2023-07-01)

Deciphering the role of signal regulatory protein α in immunotherapy for solid tumors
by: Yulong Zhou, et al.
Published: (2025-06-01)

Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application
by: Yan Pan, et al.
Published: (2025-04-01)

Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
by: Ting Zhao, et al.
Published: (2025-04-01)

Immunotherapy in the complex treatment of tumor diseases
by: V. I. Seledtsov, et al.
Published: (2022-05-01)

Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling
by: Fatjona Pupuleku Kraja, et al.
Published: (2025-05-01)

Basic and translational endocrinology
by: Maria Tereza Nunes
Published: (2025-01-01)

Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors
by: Takashi Kojima, et al.
Published: (2025-04-01)

The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years
by: Shuman Kuang, et al.
Published: (2025-08-01)

MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
by: Ravindra Pramod Deshpande, et al.
Published: (2025-03-01)

Mechanical complications of myocardial infarction: basic aspects of pathogenesis and approaches to surgical treatment
by: L. D. Shengelia, et al.
Published: (2023-07-01)

Basic Aspects of Seasonal Cardiovascular Mortality
by: G. F. Andreeva, et al.
Published: (2021-03-01)

Editorial: Harnessing single-cell insights: pioneering predictive markers for immunotherapy efficacy in solid tumors
by: Zhongbao Zhou
Published: (2025-05-01)

Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors
by: Liaoliao Zhu, et al.
Published: (2025-05-01)

Polyploid giant cancer cells and tumor budding: translation from basic research to clinical application
by: Peng Huang, et al.
Published: (2025-07-01)

Toll‐Like Receptors in the Immunotherapy Era: Dual‐Edged Swords of Tumor Immunity and Clinical Translation
by: Nueraili Maihemuti, et al.
Published: (2025-08-01)

ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors
by: Xiaoyu Jing, et al.
Published: (2025-04-01)

BASIC ASPECTS OF MANAGEMENT CONCEPT
by: E. I. Nesmeyanova
Published: (2013-03-01)

Editorial: Nanoparticles for cancer immunotherapy: from basics to clinics
by: Fernando Torres Andón, et al.
Published: (2025-08-01)

Beyond the Basics: Exploring Pharmacokinetic Interactions and Safety in Tyrosine-Kinase Inhibitor Oral Therapy for Solid Tumors
by: Laura Veronica Budău, et al.
Published: (2025-06-01)

Solid pseudopapillary tumor of the pancreas (Frantz’s tumor)
by: D. Coco, et al.
Published: (2021-11-01)

Mitophagy in the mechanisms of treatment resistance in solid tumors
by: Xiaoyi Yan, et al.
Published: (2025-07-01)

Developments in nanotechnology approaches for the treatment of solid tumors
by: Jacopo Venturini, et al.
Published: (2025-05-01)

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy
by: Brice E. N. Wamba, et al.
Published: (2025-07-01)

PHARMACOECONOMIC ASPECTS OF TREATMENT WITH THE INHIBITORS OF TUMOR NECROSIS FACTOR OF THE CHRONIC UVEITIS REFRACTORY TO THE BASIC THERAPY (INCLUDING AN ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS)
by: A.V. Rudakova
Published: (2011-08-01)

NMT-translation – basic models, quality assessment
by: I. A. Borunov
Published: (2025-01-01)

Immunotherapy for epithelial tumors of the thymus
by: O. I. Kit, et al.
Published: (2023-09-01)

Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors
by: Stephen J Forman, et al.
Published: (2025-08-01)

BASIC ASPECTS ENSURING SHIPPING SAFETY
by: Oleksiy MELNYK, et al.
Published: (2022-12-01)

Recent advances in oncolytic virus combined immunotherapy in tumor treatment
by: Xiaoli Zhou, et al.
Published: (2025-11-01)

Basic rules to respond to PD-1 blockade cancer immunotherapy
by: Antoni Ribas
Published: (2025-05-01)